Adverum Biotechnologies, Inc. (ADVM) Q2 2019 Earnings Conference Call August 08, 2019 04:30 PM ET Company Participants Myesha Lacy - Vice President of Investor Relations & Corporate Communications Leone Patterson - Chief Executive Officer Aaron Osborne - Chief Medical Officer...

Adverum Biotechnologies (NASDAQ: ADVM ): Q2 GAAP EPS of -$0.23 beats by $0.04 . More news on: Adverum Biotechnologies, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

-- Phase 1 OPTIC trial: 24-week data from first cohort to be presented at Retina Society in September; 52-week data to be presented in 1H20 -- -- Dosing of second cohort completed; 24-week data to be presented in 1H20 -- -- IND submission for ADVM-022 in diabetic retinopathy plann...